Main Logo
Menu
About Us
Our Philosophy
The Industry and Us
Our Strategy
Our Technology
Key Applications
Clinical Programs
Preclinical Programs
Pipeline
Our Partnerships
Our Team
Executive Management
Board of Directors
Clinical Advisory Board
Media / Science Center
Contact Us
Investors
All SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
In The News
Videos
Events & Presentations
Events
Presentations
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Filings & Financials
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Management Team
Investor Resources
Contacts
Email Alerts
FAQs
Investor Fact Sheet
Filing Type:
View All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
424B8
425
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
NT 10-Q
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
Date
Form
Description
PDF
XBRL
Pages
08/02/22
424B3
Prospectus filed pursuant to Rule 424(b)(3)
22
08/02/22
8-K
Current report filing
Documents
expand_more
EX-4.6
EX-4.7
22
07/29/22
DEF 14A
Definitive proxy statements
17
07/29/22
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
07/28/22
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
1
07/27/22
S-3
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-5.1
EX-23.1
EX-FILING FEES
16
07/13/22
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
17
07/08/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
07/07/22
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
expand_more
EX-99.6
8
07/06/22
8-K
Current report filing
Documents
expand_more
EX-4.6
EX-4.7
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-99.1
89
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
…
Page
47
Next Page
arrow_forward
Email Alerts
Company Profile
Contacts
RSS News Feed